2-Year Real-World Outcomes with Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: Literature Review and Meta-analysis of Patient-Relevant Outcomes-Reference-Cited by-同舟云学术

2-Year Real-World Outcomes with Intravitreal Aflibercept in Neovascular Age-Related Macular Degeneration: Literature Review and Meta-analysis of Patient-Relevant Outcomes

Published:2021-06-01 Issue:3 Volume:10 Page:397-411
ISSN:2193-8245
Container-title:Ophthalmology and Therapy
language:en
Short-container-title:Ophthalmol Ther

Author:

Carrasco Joao^ORCID,Daien Vincent,Eldem Bora M.,Spoorendonk Jelle A.,Yoon Jisu

Funder

Bayer Consumer Care AG

Publisher

Springer Science and Business Media LLC

Subject

Ophthalmology

Link

https://link.springer.com/content/pdf/10.1007/s40123-021-00350-5.pdf

Reference41 articles.

1. Flaxman SR, Bourne RRA, Resnikoff S, et al. Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis. Lancet Glob Health. 2017;5:e1221–34.

2. Ferris FL 3rd, Fine SL, Hyman L, Vision Loss Expert Group of the Global Burden of Disease Study. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol. 1984;102:1640–2.

3. Brown DM, Kaiser PK, Michels M, ANCHOR Study Group, et al. Ranibizumab versus verteporfin for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1432–44.

4. Rosenfeld PJ, Brown DM, Heier JS, MARINA Study Group, et al. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med. 2006;355:1419–31.

5. Heier JS, Brown DM, Chong V, VIEW 1 and VIEW 2 Study Groups, et al. Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology. 2012;119:2537–48.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Assistance Burden Comparison Between Age-Related Macular Degeneration and Retinal Angiomatous Proliferation Over a Three-Year Follow-up;Ophthalmic Surgery, Lasers and Imaging Retina;2024-04

2. Functional results one-year following the anti-VEGF therapy in macular pathology;Balneo and PRM Research Journal;2023-12-20

3. Intravitreal aflibercept for the treatment of patients with neovascular age-related macular degeneration in routine clinical practice in Latin America: the AQUILA study;International Journal of Retina and Vitreous;2022-10-18

4. Comparative Efficacy of Brolucizumab in the Treatment of Neovascular Age-Related Macular Degeneration: A Systematic Literature Review and Network Meta-Analysis;Advances in Therapy;2022-06-09